In this article, H&T Presspart's programme manager Benjamin Jung and US sales and business development director Dana Shears describe the role of connected devices in the treatment of asthma and COPD. They discuss the requirements for mass adoption and introduce their inhaler, the eDMI, which has connectivity fully enabled.
Non-adherence to medication is a critical problem in healthcare, especially in the area of chronic disease. The resulting economic burden across all diseases is estimated to be between $100bn and $300bn in the US and €125bn (£108bn) in Europe.
To find out more, download this free white paper.